tradingkey.logo

Rockwell Medical Inc

RMTI
查看详细走势图
1.060USD
+0.060+6.00%
收盘 02/06, 16:00美东报价延迟15分钟
41.77M总市值
亏损市盈率 TTM

Rockwell Medical Inc

1.060
+0.060+6.00%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+6.00%

5天

-0.93%

1月

+11.41%

6月

+8.16%

今年开始到现在

+27.17%

1年

-44.21%

查看详细走势图

TradingKey Rockwell Medical Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Rockwell Medical Inc当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在药品行业排名87/159位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价3.75。中期看,股价处于平稳状态。近一个月,市场表现较强,基本面评分较高,但较强的走势得没有得到技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Rockwell Medical Inc评分

相关信息

行业排名
87 / 159
全市场排名
232 / 4521
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Rockwell Medical Inc亮点

亮点风险
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
业绩高增长
公司营业收入稳步增长,连续3年增长39.39%
估值合理
公司最新PE估值-6.45,处于3年历史合理位
机构减仓
最新机构持股3.56M股,环比减少49.71%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值562.21K
活跃度增加
近期活跃度增加,过去20天平均换手率2.92

分析师目标

根据 2 位分析师
买入
评级
3.750
目标均价
+264.08%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Rockwell Medical Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Rockwell Medical Inc简介

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
公司代码RMTI
公司Rockwell Medical Inc
CEOStrobeck (Mark)
网址https://www.rockwellmed.com/
KeyAI